CT

Context Therapeutics

Biotechnology · Philadelphia, Pennsylvania, United States · Founded 2015

About

They are committed to advancing the treatment of solid tumors through the development of next-generation t cell engaging (tce) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific.

Company details may include data from People Data Labs, licensed CC BY 4.0.